An Open-Label, Dose-Escalation Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-573 in Adult Patients With Metastatic Solid Tumors
What is the purpose of this trial?
The purpose of this study is to determine the safety and tolerability of TAK-573 in participants with locally advanced or metastatic solid tumors.
- Trial withMillennium Pharmaceuticals, Inc.
- Start Date11/19/2020
- End Date08/02/2023
- Last Updated07/15/2021
- Study HIC#2000027295